METHOD FOR PREDICTING SENSITIVITY TO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR INHIBITOR

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15521566

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a method for predicting sensitivity to treatment with vascular endothelial growth factor receptor (VEGFR) inhibitors, by using a biomarker. An effective means and anticancer therapy for cancer treatment of liver cancer are selected by predicting the effect of treatment with VEGFR inhibitors on liver cancer patients through the present invention, thereby increasing the treatment effect and minimizing the side effects of liver cancer treatment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GIL MEDICAL CENTER(GUWOL-DONG) 21 NAMDONG-DAERO 774BEON-GIL NAMDONG-GU INCHEON 21565
CBSBIOSCIENCE INC26-69 GAJEONGBUK-RO YUSEONG-GU DAEJEON 34113

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Choi, Duck Joo Seoul, KR 1 0
Kim, Ju Hyun Incheon, KR 96 439
Kim, Yun Soo Seoul, KR 14 41
Kwon, Jung-Hee Daejeon, KR 4 0
Moon, Young Ho Daejeon, KR 44 96
Park, Jin Young Seoul, KR 176 910

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation